Tomoya Myojin

767 total citations
53 papers, 427 citations indexed

About

Tomoya Myojin is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tomoya Myojin has authored 53 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Cardiology and Cardiovascular Medicine and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tomoya Myojin's work include Chronic Disease Management Strategies (9 papers), Diabetes Treatment and Management (7 papers) and Health disparities and outcomes (6 papers). Tomoya Myojin is often cited by papers focused on Chronic Disease Management Strategies (9 papers), Diabetes Treatment and Management (7 papers) and Health disparities and outcomes (6 papers). Tomoya Myojin collaborates with scholars based in Japan, United States and France. Tomoya Myojin's co-authors include Tatsuya Noda, Yuichi Nishioka, Tomoaki Imamura, Shinichiro Kubo, Hitoshi Ishii, Sadanori Okada, Toshiyuki Ojima, Koshiro Kanaoka, Katsuki Okada and Yutaka Takahashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Tomoya Myojin

46 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoya Myojin Japan	14	104	83	78	68	55	53	427
Siméon-Pierre Choukem Cameroon	14	114 1.1×	69 0.8×	65 0.8×	71 1.0×	63 1.1×	41	514
Ki Heon Nam South Korea	18	89 0.9×	78 0.9×	90 1.2×	85 1.3×	98 1.8×	38	693
Chun‐Chuan Lee Taiwan	13	158 1.5×	64 0.8×	74 0.9×	137 2.0×	39 0.7×	29	533
Anat Fisher Canada	11	186 1.8×	55 0.7×	53 0.7×	85 1.3×	45 0.8×	32	451
Ravinder Garg India	13	102 1.0×	155 1.9×	37 0.5×	104 1.5×	41 0.7×	48	522
Tanya Burton United States	11	154 1.5×	60 0.7×	82 1.1×	108 1.6×	54 1.0×	32	507
Hakan Cinemre Türkiye	13	134 1.3×	84 1.0×	68 0.9×	48 0.7×	34 0.6×	48	533
Shang‐Feng Tsai Taiwan	13	90 0.9×	55 0.7×	41 0.5×	119 1.8×	105 1.9×	85	576
Mark Rutkowski United States	14	90 0.9×	37 0.4×	55 0.7×	57 0.8×	87 1.6×	18	561
Arief Wibowo Indonesia	16	72 0.7×	72 0.9×	152 1.9×	79 1.2×	70 1.3×	34	805

Countries citing papers authored by Tomoya Myojin

Since Specialization

Citations

This map shows the geographic impact of Tomoya Myojin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Myojin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Myojin more than expected).

Fields of papers citing papers by Tomoya Myojin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Myojin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Myojin. The network helps show where Tomoya Myojin may publish in the future.

Co-authorship network of co-authors of Tomoya Myojin

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Myojin. A scholar is included among the top collaborators of Tomoya Myojin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Myojin. Tomoya Myojin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakai, Michikazu, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.. (2025). Contemporary Use of Oral Inotropes in the Outpatient Treatment of Heart Failure: Analysis of a Japanese Nationwide Database. The Journal of Clinical Pharmacology. 65(8). 1039–1048. 1 indexed citations

Kanaoka, Koshiro, Yoshitaka Iwanaga, Tetsuo Sasano, et al.. (2025). Anticoagulation Therapy for Atrial Fibrillation After Transcatheter Aortic Valve Replacement: National Database Insights. Journal of the American Heart Association. 14(13). e040030–e040030.

Nishioka, Yuichi, Sadanori Okada, Tomoya Myojin, et al.. (2025). Multiple or Single Endocrine Abnormalities Associated With Immune Checkpoint Inhibitors. The Journal of Clinical Endocrinology & Metabolism. 111(1). 54–61. 2 indexed citations

Noda, Tatsuya, Tomoya Myojin, Yuichi Nishioka, et al.. (2025). Incidence and risk of cancer emergence among patients post-kidney transplantation in Japan. PubMed. 29(12). 1892–1901.

Okada, Sadanori, Yuichi Nishioka, Koshiro Kanaoka, et al.. (2024). Annual variation of estimated glomerular filtration rate in health check-ups associated with end-stage kidney disease. Scientific Reports. 14(1). 21065–21065.

Nishioka, Yuichi, Hiroki Nakajima, Sadanori Okada, et al.. (2024). Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association. Journal of Diabetes Investigation. 16(2). 334–342. 5 indexed citations

Nishioka, Yuichi, Hiroki Nakajima, Sadanori Okada, et al.. (2024). Novel subgroups of obesity and their association with outcomes: a data-driven cluster analysis. BMC Public Health. 24(1). 124–124. 4 indexed citations

Kanaoka, Koshiro, Yoshitaka Iwanaga, Katsuki Okada, et al.. (2023). Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims. Circulation Journal. 87(4). 536–542. 15 indexed citations

Kanaoka, Koshiro, Yoshitaka Iwanaga, Michikazu Nakai, et al.. (2023). Sodium–glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure. European Heart Journal - Cardiovascular Pharmacotherapy. 9(5). 444–452. 5 indexed citations

10.

Kanaoka, Koshiro, Yoshitaka Iwanaga, Michikazu Nakai, et al.. (2023). Reduction in Planned Percutaneous Coronary Interventions After the Policy Change for Ischemia Assessment in Japan. JACC Asia. 3(2). 312–314. 3 indexed citations

11.

Kanaoka, Koshiro, Taku Nishida, Yoshitaka Iwanaga, et al.. (2023). Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks. European Heart Journal. 45(7). 522–534. 13 indexed citations

12.

Hosokawa, Rikuya, Toshiyuki Ojima, Tomoya Myojin, et al.. (2023). Association between the Standardized Mortality Ratio and Healthy Life Expectancy in Japan. JMA Journal. 6(1). 27–35. 1 indexed citations

13.

Nishioka, Yuichi, Shinichiro Kubo, Sadanori Okada, et al.. (2022). The age of death in Japanese patients with type 2 and type 1 diabetes: A descriptive epidemiological study. Journal of Diabetes Investigation. 13(8). 1316–1320. 6 indexed citations

14.

Sato, Sakura, Tatsuya Noda, Motohiro Ebisawa, et al.. (2022). Evaluation of adrenaline auto-injector prescription profiles: A population-based, retrospective cohort study within the National Insurance Claims Database of Japan. Allergology International. 71(3). 354–361.

15.

Kubo, Shinichiro, Tatsuya Noda, Tomoya Myojin, et al.. (2022). Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deaths. Clinical and Experimental Nephrology. 26(4). 360–367. 7 indexed citations

16.

Kanaoka, Koshiro, Yoshitaka Iwanaga, Michikazu Nakai, et al.. (2022). Hospital- and Patient-Level Analysis of Quality Indicators in Acute Coronary Syndrome Care: A Nationwide Database Study. Canadian Journal of Cardiology. 39(4). 515–523. 1 indexed citations

17.

Nakai, Michikazu, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.. (2022). Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society. Cardiovascular Diabetology. 21(1). 157–157. 10 indexed citations

18.

Nishioka, Yuichi, Tatsuya Noda, Sadanori Okada, et al.. (2021). Association between influenza and the incidence rate of new‐onset type 1 diabetes in Japan. Journal of Diabetes Investigation. 12(10). 1797–1804. 14 indexed citations

19.

Akahane, Manabu, Tomoya Myojin, Shinichiro Kubo, et al.. (2021). Long‐term prognosis of enteral feeding and parenteral nutrition in a population aged 75 years and older: a population‐based cohort study. BMC Geriatrics. 21(1). 80–80. 7 indexed citations

20.

Fujii, Tomomi, Tomoko Uchiyama, Tomoya Myojin, et al.. (2020). Evaluation of DNA and RNA quality from archival formalin‐fixed paraffin‐embedded tissue for next‐generation sequencing – Retrospective study in Japanese single institution. Pathology International. 70(9). 602–611. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact